Rating History for Aslan Pharma (ASLN) by Roth/MKM

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
5/31/2023 Dylan Dupuls New Coverage Buy
(N/A)
15.00
(N/A)
3.91
(0.60)
-84.65% Details